CN Stock MarketDetailed Quotes

000739 Apeloa Pharmaceutical

Watchlist
  • 16.15
  • +0.05+0.31%
Trading Nov 4 14:09 CST
18.88BMarket Cap17.59P/E (TTM)

Apeloa Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apeloa Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 18, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
2.86B
--
+12.41%
Net Income
--
244.74M
--
-2.21%
Analyst Rating
Strong Buy

Nov 4, 2024

Apeloa Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 14.510B--
--2024/FY-- / 12.899B--
Mar 8, 20242023/FY11.474B / 12.031B--
Mar 10, 20232022/FY10.545B / 10.075B--
--2021/FY8.943B / 9.138B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 14.510B--
--2024/FY-- / 12.899B--
Mar 8, 20242023/FY11.474B / 12.031B--
Mar 10, 20232022/FY10.545B / 10.075B--
--2021/FY8.943B / 9.138B--

Unlock Free Earnings Estimates

Apeloa Pharmaceutical Earnings Reports

  • Prologis Pharmaceuticals: Report for the third quarter of 2024

    Oct 17 12:00 ET

  • Apeloa Pharmaceutical: Summary of Half-Year Report in 2024.

    Aug 15 12:00 ET

  • Apeloa Pharmaceutical: Half-year report for the year 2024.

    Aug 15 12:00 ET

  • Prologis Pharmaceuticals: Report for the first quarter of 2024

    Apr 17 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 4, 2024

    Strong Buy

    • Strong Buy

      77.78%

    • Buy

      22.22%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data